{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:24:37Z","timestamp":1783977877051,"version":"3.55.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ajem.2021.01.033","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T09:59:24Z","timestamp":1611482364000},"page":"11-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Euglycemic diabetic ketoacidosis associated with SGLT2i use: Case series"],"prefix":"10.1016","volume":"44","author":[{"given":"Henrique A.","family":"Puls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan L.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nik","family":"Theyyunni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie E.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ajem.2021.01.033_bb0005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ajem.2021.01.033_bb0010","series-title":"StatPearls [Internet]","article-title":"Euglycemic Diabetic Ketoacidosis","author":"Plewa","year":"2020"},{"key":"10.1016\/j.ajem.2021.01.033_bb0015","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.2337\/dc17-1721","article-title":"SGLT2 inhibitor\u2013associated euglycemic diabetic ketoacidosis: a south Australian clinical case series and Australian spontaneous adverse event notifications","volume":"41","author":"Meyer","year":"2018","journal-title":"Diabetes Care"},{"issue":"9786","key":"10.1016\/j.ajem.2021.01.033_bb0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.ajem.2021.01.033_bb0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/0897190018815048","article-title":"National Trends in diabetes medication use in the United States: 2008 to 2015","volume":"33","author":"Raval","year":"2020","journal-title":"J Pharm Pract"},{"issue":"12","key":"10.1016\/j.ajem.2021.01.033_bb0030","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/dme.13791","article-title":"SGLT2 inhibitors in Type 1 diabetes: is this the future?","volume":"35","author":"Herring","year":"2018","journal-title":"Diabet Med"},{"issue":"15","key":"10.1016\/j.ajem.2021.01.033_bb0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Et al; EMPEROR-reduced trial investigators. Cardiovascular and renal outcomes with Empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.ajem.2021.01.033_bb0040","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2021.01.033_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7074868","article-title":"Newer perspectives of mechanisms for Euglycemic diabetic ketoacidosis","volume":"2018","author":"Yu","year":"2018","journal-title":"Int J Endocrinol"},{"issue":"9","key":"10.1016\/j.ajem.2021.01.033_bb0050","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.ajem.2021.01.033_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.7584","article-title":"Association of an Emergency Department-Based Intensive Care Unit With Survival and Inpatient Intensive Care Unit Admissions","volume":"2","author":"Gunnerson","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.ajem.2021.01.033_bb0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jemermed.2018.01.004","article-title":"The two-bag method for treatment of diabetic ketoacidosis in adults","volume":"54","author":"Haas","year":"2018","journal-title":"J Emerg Med"},{"issue":"4","key":"10.1016\/j.ajem.2021.01.033_bb0065","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jemermed.2019.10.005","article-title":"An emergency department-based intensive care unit is associated with decreased hospital and intensive care unit utilization for diabetic ketoacidosis","volume":"58","author":"Haas","year":"2020","journal-title":"J Emerg Med"},{"issue":"6","key":"10.1016\/j.ajem.2021.01.033_bb0070","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4158\/EP161292.PS","article-title":"American Association of Clinical Endocrinologists and American College of endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis","volume":"22","author":"Handelsman","year":"2016","journal-title":"Endocr Pract"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572100036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073567572100036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:51:47Z","timestamp":1760025107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073567572100036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":14,"alternative-id":["S073567572100036X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2021.01.033","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Euglycemic diabetic ketoacidosis associated with SGLT2i use: Case series","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2021.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}